Brevan Howard Capital Management »

Inmune Bio Ord shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $193k 16k 11.75

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option (XLF)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)
Ametek (AME)
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Msci Eafe Index Fund Msci Eafe Etf Call Option (EFA)
Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)
Ishares Russell 2000 Etf Russell 2000 Etf Call Option (IWM)
Health Care Select Secto Sbi Heathcare Call Option (XLV)
ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)
Spdr S&p Biotech Etf S&p Biotech Call Option (XBI)
Energy Select Sector Spdr Energy Call Option (XLE)
Spdr Metals & Mining Etf S&p Metals Mng Call Option (XME)
Streettracks Gold Trust Gold Shs Call Option (GLD)
SEMICONDUCTOR HOLDRs TRUST Semiconductr Etf (SMH)

View all positions for Brevan Howard Capital Management

Top funds holding Inmune Bio Ord

Vanguard Group
BlackRock
MAI Wealth Advisors
Rhenman & Partners Asset Management AB
Susquehanna International
Geode Capital Management
Millennium Management
Janney Montgomery Scott
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group
Royal Bank of Canada
Jane Street
Citigroup
State Street Corporation
Qube Research & Technologies

View all funds holding Inmune Bio Ord